Sign in to view content

Long Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Recurrent or Persistent Neovascular Age-Releated Macular Degeneration

ILKAY KILIC MUFTUOGLU, MD

Video
Published 2016

Related

Episode 22: Stroke Risk in Patients with CRAO with Dr. Matthew Schrag
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019
Prospective Trial Comparing Ranibizumab Monthly to Treat and Extent With and Without Angiography-Guided Laser for DME
John F. Payne, MD
Updates from the Field
2016
Canadian Treat-and-Extend Trial With Ranibizumab in nAMD Patients: CANTREAT 36-Month Extension Results
Peter J. Kertes, MD, FRCS(C)
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more